HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pending FDA User-Fee Legislation May Be ‘Big Shot’ For Cosmetics Reg Reform

This article was originally published in The Rose Sheet

Executive Summary

The Personal Care Products Council expects at least three cosmetics reform bills to make reappearances in the 115th Congress, but the best opportunity for updating regulations may involve tacking related provisions onto must-pass FDA user-fee bills this year. Top execs discussed the current legislative landscape during the “Washington Report” session of the trade group’s annual meeting in Palm Beach, Fla.


Related Content

Cosmetics Reg Reform Ill-Situated As Trump, FDA Explore 'Burden Reduction'
ICMAD Broadens Advocacy Focus With Cosmetics Reform A Low Priority In Congress
Cosmetics Provisions Unlikely To Catch Ride On FDA User-Fee Bill
Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?
FDA Commish Nominee Could Be Mixed Blessing For Cosmetics Industry
Hawaii Bills Seek Ban On Oxybenzone-Containing Sunscreens
Obamacare Repeal May Be Delaying User Fee Bill, Rep. DeGette Says
PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises
House Cosmetics Bill Reintroduced; ICMAD Optimistic In New Political Climate
ICMAD Looks To Sway Legislators To Sessions Cosmetics Bill





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts